A Study of Teduglutide in Chinese Adults With Short Bowel Syndrome
Takeda · Short Bowel Syndrome
Phase 3
Recruiting
13
2026-06
Industry sponsor intelligence
TakedaClinical Pipeline.
Lead-sponsor view of Takeda's indexed peptide studies, development phases, active programs, completed work and recent registry changes.
- Total
- 15
- Recruiting
- 3
- Active
- 1
- Completed
- 11
- Results posted
- 3
- Avg enrollment
- 7
Pipeline overview
Programs by phase and activity.
Velocity
Takeda trials by start year
Study start year · indexed snapshot
Development
Trials by phase
4phase labels
Early Phase 10
Phase 10
Phase 20
Phase 34
Phase 40
| Product | Studies | Early / I | Phase II | Phase III | Phase IV | Active |
|---|---|---|---|---|---|---|
| Teduglutide → | 9 | 0 | 0 | 3 | 0 | 4 |
| Icatibant → | 5 | 0 | 0 | 1 | 0 | 0 |
| Leuprolide → | 1 | 0 | 0 | 0 | 0 | 0 |
Active peptide trials
In motion now.
NCT IDStudyPhase / statusEnrollmentUpdated
A Study of Teduglutide in Japanese People With Short Bowel Syndrome
Takeda · Short Bowel Syndrome
Not applicable
Active, not recruiting
250
2026-04
A Study of Teduglutide in Chinese Children and Teenagers With Short Bowel Syndrome
Takeda · Short Bowel Syndrome (SBS)
Not applicable
Recruiting
12
2026-03
A Survey to Assess Participants' and Physicians' Knowledge When Using GATTEX (Knowledge Assessment Survey)
Takeda · Short Bowel Syndrome (SBS)
Not applicable
Recruiting
600
2026-01
Completed trials
Finished registry records.
NCT IDStudyPhase / statusEnrollmentUpdated
A Survey of Icatibant in Pediatric Participants With Hereditary Angioedema
Takeda · Hereditary Angioedema (HAE)
Not applicable
Completed
32
2026-07
Specified Drug-Use Survey of Leuprorelin Acetate Injection Kit 11.25 mg "All-Case Investigation: Spinal and Bulbar Muscular Atrophy (SBMA)"
Takeda · Spinal and Bulbar Muscular Atrophy
Not applicable
Completed
1,905
2026-05
A Study of Lanadelumab (Takhzyro) and Icatibant (Firazyr®) in Persons With HAE in China
Takeda · Hereditary Angioedema (HAE)
Not applicable
Completed
115
2026-01
A Study of Teduglutide (Revestive®) in Participants With Short Bowel Syndrome (SBS) in Canada
Takeda · Short Bowel Syndrome (SBS)
Not applicable
Completed
52
2025-04
A Study to Explore Hereditary Angioedema (HAE) Symptoms and Treatment Patterns in Korean People
Takeda · Hereditary Angioedema (HAE)
Not applicable
Completed
19
2025-02
A Study in Adults With Hereditary Angioedema (HAE) Who Currently Receive Icatibant at Home
Takeda · Hereditary Angioedema (HAE)
Not applicable
Completed
85
2024-08
A Study of Teduglutide in Japanese Children With Short Bowel Syndrome Aged 4 Months or Older
Takeda · Short Bowel Syndrome
Phase 3
Completed
3
2024-05
A Study With Teduglutide (Revestive®) in Adults With Short Bowl Syndrome
Takeda · Short Bowel Syndrome
Not applicable
Completed
65
2023-08
A Study of Teduglutide (Revestive®) in Children, Teenagers and Adults With Short Bowel Disease
Takeda · Short Bowel Syndrome
Not applicable
Completed
45
2023-07
An Extension Study of Teduglutide in Japanese Participants With Short Bowel Syndrome Who Completed 24 Weeks of Treatment in SHP633-306 or TED-C14-004
Takeda · Short Bowel Syndrome
Phase 3
Completed
11
2023-03
Showing 10 of 11 studies
Search sponsor records
All Takeda studies.
This page groups studies where Takeda is listed as the lead industry sponsor. Collaborator-only records are not included in the count.
15 matching studies
Last registry update first
Recent updates
Latest registry movement.
NCT05509569A Survey of Icatibant in Pediatric Participants With Hereditary AngioedemaJul 8, 2026NCT06973304A Study of Teduglutide in Chinese Adults With Short Bowel SyndromeJun 24, 2026NCT03555578Specified Drug-Use Survey of Leuprorelin Acetate Injection Kit 11.25 mg "All-Case Investigation: Spinal and Bulbar Muscular Atrophy (SBMA)"May 22, 2026NCT05023382A Study of Teduglutide in Japanese People With Short Bowel SyndromeApr 13, 2026NCT07319832A Study of Teduglutide in Chinese Children and Teenagers With Short Bowel SyndromeMar 13, 2026NCT05561647A Survey to Assess Participants' and Physicians' Knowledge When Using GATTEX (Knowledge Assessment Survey)Jan 26, 2026NCT06346899A Study of Lanadelumab (Takhzyro) and Icatibant (Firazyr®) in Persons With HAE in ChinaJan 21, 2026NCT05371028A Study of Teduglutide (Revestive®) in Participants With Short Bowel Syndrome (SBS) in CanadaApr 6, 2025NCT06587464A Study to Explore Hereditary Angioedema (HAE) Symptoms and Treatment Patterns in Korean PeopleFeb 10, 2025NCT05489640A Study in Adults With Hereditary Angioedema (HAE) Who Currently Receive Icatibant at HomeAug 5, 2024